Skip to content
  • News
  • Events
  • Lists
  • Life
  • Magazine
  • Sign-in
  • Subscribe

medicine

Parkinson’s Disease drug Tavapadon significantly improved symptom control, Cerevel says

Patients who used the drug experienced more time without experiencing involuntary and erratic movements.

  • By Ty Roush
  • Forbes Staff

FDA approves first medication for treating allergic reactions to multiple foods

The U.S. Food and Drug Administration approved the use of Xolair to reduce the severity of allergic reactions to one or more foods, making it the first FDA-approved medication to treat allergic reactions to multiple foods from accidental exposure.

  • By Cailey Gleeson

‘Game-changing’ new Parkinson’s test paves way for treatments and cure

The test, capable of detecting Parkinson’s before the onset of symptoms, “launches a new, biological era in Parkinson’s research” and could pave the way for a cure, said researcher Kenneth Marek.

  • By Robert Hart
  • Forbes Staff

Breakthrough for one of the world’s biggest killers— as new vaccine shows early promise

Tuberculosis is one of humanity’s biggest killers and the only licensed TB vaccine, BCG, was developed more than 100 years ago.

  • By Robert Hart
  • Forbes Staff
We use cookies to help us to deliver our services and provide personalised experiences. By using this website you agree to use our cookies. Cookie Policy

The best of Forbes, delivered to your inbox

I accept Forbes Australia's Terms and Privacy Policy

All set

Please check your inbox to confirm your subscription. Welcome to the Forbes community

 

  • Sections
    • News
    • Events
    • Lists
    • Life
  • Company
    • About us
    • Contact us
    • Careers
    • Advertise with us
    • Media
  • Explore
    • Billionaires
    • Entrepreneurs
    • Innovation
    • Leadership
Social
  • Facebook
  • LinkedIn
  • Instagram
  • Twitter
  • YouTube

Magazines covers

Get the magazine delivered with a Premium membership, find it at all good newsagents, or purchase previous issues online.

© 2025 Success Publishing Pty Ltd including content reproduced under license from Forbes IP (HK) LTD. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • News
  • Events
  • Lists
  • Life
  • Magazine
  • Subscribe
  • Sign-in